Table 1 Patient demographics.
Patient characteristics | Duration of therapy | |
|---|---|---|
< 3months (n = 53) | > 12 months (n = 35) | |
Age (at initial visit) | 20–86 (65) | 36–83 (62) |
Sex | ||
Male | 33 (62%) | 21 (60%) |
Female | 20 (38%) | 14 (40%) |
TumorType | ||
Melanoma | 4 (7.5%) | 11 (31.4%) |
Lung | 9 (17%) | 5 (14.3%) |
Sarcoma | 6 (11.3%) | 4 (11.4%) |
Head and neck | 8 (15.1%) | 3 (8.6%) |
Renal | 3 (5.7%) | 2 (5.7%) |
Basal cell carcinoma of parotid | 0 (0%) | 1 (2.9%) |
Basaloid squamous cell carcinoma of skin | 0 (0%) | 1 (2.9%) |
Esophageal | 5 (9.4%) | 1 (2.9%) |
Bladder/Urothelial | 4 (7.5%) | 1 (2.9%) |
Colorectal | 3 (5.7%) | 1 (2.9%) |
Unknown primary | 2 (3.8%) | 1 (2.9%) |
Hepatocellular | 1 (1.9%) | 1 (2.9%) |
Squamous cell carcinoma of skin | 0 (0%) | 1 (2.9%) |
Acinar cell carcinoma of parotid | 0 (0%) | 1 (2.9%) |
Thyroid | 0 (0%) | 1 (2.9%) |
Breast | 3 (5.7%) | 0 (0%) |
Anal | 1 (1.9%) | 0 (0%) |
Testis | 1 (1.9%) | 0 (0%) |
Pancreas | 1 (1.9%) | 0 (0%) |
Prostate | 1 (1.9%) | 0 (0%) |
Uterine | 1 (1.9%) | 0 (0%) |
